Status:

COMPLETED

Donepezil in the Prevention of Post-Operative Cognitive Decline

Lead Sponsor:

Pfizer

Conditions:

Postoperative Complications

Delirium

Eligibility:

All Genders

65+ years

Phase:

PHASE4

Brief Summary

The purpose of this study is to evaluate the feasibility of using Donepezil to prevent post-operative cognitive decline (POCD) among individuals aged 65 and older who have a baseline mild cognitive im...

Detailed Description

Up to 65% of elderly patients undergoing hip or knee surgery suffer from declining brain function known as post-operative cognitive decline (POCD). These individuals often stay in the hospital longer,...

Eligibility Criteria

Inclusion

  • Community-dwelling individuals aged 65 or older
  • Scheduled for elective hip or knee replacement at University Hospital
  • Mild cognitive impairment, defined as:
  • MMSE total score of 27 or less;
  • normal performance of the activities of daily living tasks of the Bristol scale after excluding mobility related difficulties;
  • no chart-based dementia diagnosis; and
  • no history of ever being on dementia medications such as Memantine or any cholinesterase inhibitors
  • Consent to participate in the study

Exclusion

  • Chart-based dementia diagnosis
  • MMSE score greater than 27
  • Difficulty performing the activities of daily living not related to mobility as measured by the Bristol scale
  • Current or past history of receiving dementia medications such as Memantine or any cholinesterase inhibitors (Tacrine, Donepezil, Rivastigmine, or Galantamine)
  • Metastatic cancer or other comorbid illnesses likely to reduce life expectancy to under 6 months
  • Multiple trauma or pathological fractures requiring acute hip or knee replacement
  • Aphasic, blind, or deaf
  • Use of neuroleptics one month prior to surgery
  • Allergy to donepezil
  • Inability to read and complete study tests and forms
  • Alcohol or drug dependence, defined as intake of more than 5 units of alcohol daily during the past 3 months
  • Not expected to be discharged from hospital or able to complete the 3-month postoperative test
  • Not competent to make medical decisions

Key Trial Info

Start Date :

February 1 2005

Trial Type :

INTERVENTIONAL

End Date :

April 1 2007

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT00182845

Start Date

February 1 2005

End Date

April 1 2007

Last Update

March 3 2008

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Hospital, Clarian Health Partners

Indianapolis, Indiana, United States, 46202

Donepezil in the Prevention of Post-Operative Cognitive Decline | DecenTrialz